Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) Clinical research trials and Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion). Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) clinical trial. Participants typically obtain the most effective healthcare available for their Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion) condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "T" Clinical Trials Conditions > Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)



Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

For Condition: Alcoholism,Attention Deficit Hyperactivity Disorder
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This study will compare the effectiveness of sustained release bupropion (Wellbutrin) versus a placebo in the treatment of adolescents with comorbid alcohol use disorder and attention deficit hyperactivity disorder. Adolescents, ages 14-18 will be recruited from community treatment programs for a 16-week trial with follow-up assessments.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Double-Blind, Placebo Control, Parallel Assignment
Minimum Age/Maximum Age: 14 Years/18 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Meets criteria for alcohol use disorder and attention deficit hyperactivity disorder. - Adolescents, ages 14-18. Exclusion Criteria: - Adolescents who are pregnant. - Have a history of seizure disorder, other neurological or medical disorder for which medication treatment may present a considerable risk. - History of pervasive development disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders. - Currently on other psychotropic medications from which discontinuation would present a significant risk. - A current episode of major depressive disorder or a diagnosis of bipolar disorder. - Diagnosis of dependence for any substance other than marijuana. - Adolescents with a full-scale IQ below 80.
Total Enrollment: 80

Location and Contact Information:

Western Psychiatric Institute and Clinic *Recruiting*
Pittsburgh,  Pennsylvania,  15213
United States
Recruiting Dr.  Bukstein 412-624-9167


Additional Information:
Study ID Numbers:
  NIAAABUK00301; 
Study Start Date: September 2001
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00029614

Other Attention Deficit Hyperactivity Disorder Studies:
1. Treating Alcohol Use In Older Adults With Depression

2. Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal

3. Combination Nicotine Replacement for Alcoholic Smokers

4. Drug Treatment for Alcoholics with Post-Traumatic Stress Disorder

5. Behavior and Naltrexone Treatment for Alcoholics

Related Studies:

Other Attention Deficit Hyperactivity Disorder Clinical Trials
Other Pennsylvania Clinical Trials
Other Pittsburgh Clinical Trials

Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)

Modify your Search

  Other Attention Deficit Hyperactivity Disorder Clinical Trials
  Other Pennsylvania Clinical Trials
  Other Pittsburgh Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103